Back

Small dense low-density lipoprotein cholesterol potentiates the risk of Lp(a) for long-term secondary prevention in patients with stable coronary artery disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (1) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Shinji Koba

Showa Medical University Hospital, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
Association of atherogenic index of plasma trajectory with the incidence of cardiovascular disease over a 12-year follow-up: findings from the ELSA cohort study
Doctor X. Li (Kunming, CN)
Abstract Slides Video
Presentation thumbnail
Coronary artery disease and the bad dual: homocysteine and lipoprotein (a)
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic value of cardiac myosin binding protein C in the general population: The Akershus Cardiac Examination 1950 Study
Doctor M. Lyngbakken (Nordbyhagen, NO)
Abstract Slides Video
Presentation thumbnail
Clonal Hematopoiesis and Cardiovascular Outcomes in the Elderly
Mr D. Ezzat (BE)
Abstract Slides Video
Presentation thumbnail
Remnant cholesterol-inflammatory index predicts antiplatelet reactivity and 5-year ischemic risk: a cohort study of 6,555 post-PCI patients
Miss M. Liu (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Impact of measured or calculated small dense LDL cholesterol compared with apolipoprotein B or non-HDL cholesterol for long-term secondary prevention in patients with stable coronary artery disease
thumbnail
Congress Presentation
Comparison of lipoprotein (a) levels in patients with a history of coronary artery disease and in normal subjects
thumbnail
Congress Presentation
Association of elevated lipoprotein(a) with future major adverse cardiovascular events in recurrent ASCVD patients: analysis of a large US electronic health record database

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources